Comparative Clinical Study of Warfarin and Rivaroxaban (Newer Anti-Coagulant) with Respect to Efficacy and Side Effects in the Treatment of Peripheral Venous Thromboembolism

Journal: International Journal of Science and Research (IJSR) (Vol.8, No. 11)

Publication Date: 2019-11-05

Authors : Thrishankareddy P;

Page : 222-232

Keywords : Venous thromboembolism; Warfarin; Rivaroxaban; Bleeding;

Source : Download Find it from : Google Scholar

Abstract

New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have become available as an alternative to warfarin anticoagulation in peripheral venous thromboembolism. We assessed the effectiveness and safety along with side effects of rivaroxaban vs warfarin in patients experiencing venous thromboembolism (both deep vein thrombosis and pulmonary embolism)

Main Menu

Searching By

PARTNERS

Comparative Clinical Study of Warfarin and Rivaroxaban (Newer Anti-Coagulant) with Respect to Efficacy and Side Effects in the Treatment of Peripheral Venous Thromboembolism

Abstract

Advertisement